Explore Decure’s sourcing portfolio across injectables, tablets, capsules, dry syrups, topical formulations and specialized therapeutic ranges, with multiple strengths, compositions and dosage-form options for institutional and commercial requirements.
8+Product Categories
500+Product Variants
MultipleDosage Forms
GMPQuality Sourced
Sterile injectable formulations for institutional and hospital requirements.
Beta-Lactam and Non-Beta-Lactam formulations across therapeutic categories.
Hard-shell capsule formulations in multiple strengths and compositions.
Paediatric and adult oral liquid and dry-syrup formulation options.
Creams, ointments and other topical dosage-form requirements.
Formulations supporting diabetes-management sourcing requirements.
Cardiovascular formulations across common dosage forms and strengths.
Page 3 of 5
Film-Coated Tablet
Clarithromycin 500 mg Film-Coated Tablet is a film-coated tablet formulated with 500 mg. The active ingredient profile is Clarithromycin, placing the product in the macrolide antibiotic category. Clarithromycin is a macrolide antibiotic that inhibits bact
Film-Coated Tablet
Colistin 80 mg Film-Coated Tablet is a film-coated tablet formulated with 80 mg. The active ingredient profile is Colistin, placing the product in the polymyxin antibiotic category. Colistin is a polymyxin-class antibacterial used in selected settings aga
Film-Coated Tablet
Deflazacort 12 mg Film-Coated Tablet is a film-coated tablet formulated with 12 mg. The active ingredient profile is Deflazacort, placing the product in the corticosteroid category. Deflazacort is a systemic corticosteroid with anti-inflammatory and immun
Uncoated Tablet
Deflazacort 6 mg Uncoated Tablet is a uncoated tablet formulated with 6 mg. The active ingredient profile is Deflazacort, placing the product in the corticosteroid category. Deflazacort is a systemic corticosteroid with anti-inflammatory and immunosuppres
Film-Coated Tablet
Diclofenac 50 mg + Paracetamol 325 mg + Trypsin-Chymotrypsin 50,000 AU Film-Coated Tablet is a film-coated tablet formulated with Diclofenac 50 mg + Paracetamol 325 mg + Trypsin-Chymotrypsin 50,000 AU. The active ingredient profile is Diclofenac; Paraceta
Uncoated Tablet
Diclofenac Potassium 50 mg + Acetaminophen 325 mg + Chlorzoxazone 250 mg Uncoated Tablet is a uncoated tablet formulated with Diclofenac Potassium 50 mg + Acetaminophen 325 mg + Chlorzoxazone 250 mg. The active ingredient profile is Diclofenac Potassium;
Uncoated Tablet
Diclofenac Potassium 50 mg + Paracetamol 325 mg + Chlorpheniramine Maleate 4 mg + Magnesium Trisilicate 100 mg Uncoated Tablet is a uncoated tablet formulated with Diclofenac Potassium 50 mg + Paracetamol 325 mg + Chlorpheniramine Maleate 4 mg + Magnesium
Film-Coated Tablet
Diclofenac Potassium 50 mg + Paracetamol 325 mg + Chlorzoxazone 250 mg Film-Coated Tablet is a film-coated tablet formulated with Diclofenac Potassium 50 mg + Paracetamol 325 mg + Chlorzoxazone 250 mg. The active ingredient profile is Diclofenac Potassium
Uncoated Tablet
Diclofenac Potassium 50 mg + Paracetamol 325 mg + Chlorzoxazone 250 mg Uncoated Tablet is a uncoated tablet formulated with Diclofenac Potassium 50 mg + Paracetamol 325 mg + Chlorzoxazone 250 mg. The active ingredient profile is Diclofenac Potassium; Para
Tablet
Diclofenac Potassium 50 mg + Paracetamol 325 mg + Chymotrypsin 50,000 IU Tablet is a tablet formulated with Diclofenac Potassium 50 mg + Paracetamol 325 mg + Chymotrypsin 50,000 IU. The active ingredient profile is Diclofenac Potassium; Paracetamol; Chymo
Film-Coated Tablet
Diclofenac Potassium 50 mg + Paracetamol 325 mg + Serratiopeptidase 10 mg Film-Coated Tablet is a film-coated tablet formulated with Diclofenac Potassium 50 mg + Paracetamol 325 mg + Serratiopeptidase 10 mg. The active ingredient profile is Diclofenac Pot
Uncoated Tablet
Diclofenac Potassium 50 mg + Paracetamol 325 mg Uncoated Tablet is a uncoated tablet formulated with Diclofenac Potassium 50 mg + Paracetamol 325 mg. The active ingredient profile is Diclofenac Potassium; Paracetamol, placing the product in the nsaid + an
Film-Coated Tablet
Diclofenac Potassium 50 mg + Serratiopeptidase 10 mg Film-Coated Tablet is a film-coated tablet formulated with Diclofenac Potassium 50 mg + Serratiopeptidase 10 mg. The active ingredient profile is Diclofenac Potassium; Serratiopeptidase, placing the pro
Uncoated Tablet
Diclofenac Sodium 50 mg + Paracetamol 325 mg + Chlorpheniramine Maleate 4 mg + Magnesium Trisilicate 100 mg Uncoated Tablet is a uncoated tablet formulated with Diclofenac Sodium 50 mg + Paracetamol 325 mg + Chlorpheniramine Maleate 4 mg + Magnesium Trisi
Uncoated Tablet
Diclofenac Sodium 50 mg + Paracetamol 325 mg Uncoated Tablet is a uncoated tablet formulated with Diclofenac Sodium 50 mg + Paracetamol 325 mg. The active ingredient profile is Diclofenac Sodium; Paracetamol, placing the product in the nsaid + analgesic c
Enteric-Coated Tablet
Divalproex Sodium 125 mg Enteric-Coated Tablet is a enteric-coated tablet formulated with 125 mg. The active ingredient profile is Divalproex Sodium, placing the product in the anticonvulsant / mood-stabilizing agent category. Divalproex Sodium is an anti
Extended-Release Tablet
Divalproex Sodium Extended-Release 1000 mg Tablet is a extended-release tablet formulated with 1000 mg. The active ingredient profile is Divalproex Sodium, placing the product in the anticonvulsant / mood-stabilizing agent category. Divalproex Sodium is a
Uncoated Tablet
Drotaverine 40 mg Uncoated Tablet is a uncoated tablet formulated with 40 mg. The active ingredient profile is Drotaverine, placing the product in the antispasmodic category. The active ingredient is an antispasmodic intended to reduce smooth-muscle spasm
Tablet
Drotaverine 80 mg + Aceclofenac 100 mg Tablet is a tablet formulated with Drotaverine 80 mg + Aceclofenac 100 mg. The active ingredient profile is Drotaverine; Aceclofenac, placing the product in the antispasmodic + nsaid combination category. The formula
Film-Coated Tablet
Drotaverine Hydrochloride 80 mg + Mefenamic Acid 250 mg Film-Coated Tablet is a film-coated tablet formulated with Drotaverine Hydrochloride 80 mg + Mefenamic Acid 250 mg. The active ingredient profile is Drotaverine Hydrochloride; Mefenamic Acid, placing
Film-Coated Tablet
Etoricoxib 120 mg Film-Coated Tablet is a film-coated tablet formulated with 120 mg. The active ingredient profile is Etoricoxib, placing the product in the selective cox-2 nsaid category. The formulation contains an NSAID and/or non-opioid analgesic comp
Film-Coated Tablet
Etoricoxib 60 mg + Paracetamol 325 mg Film-Coated Tablet is a film-coated tablet formulated with Etoricoxib 60 mg + Paracetamol 325 mg. The active ingredient profile is Etoricoxib; Paracetamol, placing the product in the cox-2 nsaid + analgesic combinatio
Film-Coated Tablet
Faropenem Sodium 200 mg + Potassium Clavulanate Eq. to Clavulanic Acid 125 mg Film-Coated Tablet is a film-coated tablet formulated with Faropenem Sodium 200 mg + Potassium Clavulanate equivalent to Clavulanic Acid 125 mg. The active ingredient profile is
Film-Coated Tablet
Flavoxate 20 mg Film-Coated Tablet IP is a film-coated tablet formulated with 20 mg. The active ingredient profile is Flavoxate, placing the product in the urinary antispasmodic category. Flavoxate is a urinary antispasmodic used for symptomatic relief of
Film-Coated Tablet
Flavoxate HCl 200 mg + Ofloxacin 200 mg Film-Coated Tablet is a film-coated tablet formulated with Flavoxate HCl 200 mg + Ofloxacin 200 mg. The active ingredient profile is Flavoxate HCl; Ofloxacin, placing the product in the urinary antispasmodic + antib
GMP Certified Manufacturers
Wide Product Portfolio
Multiple Dosage Forms
Global Supply Network
Regulatory Documentation
Competitive PricingOur sourcing experts are ready to help with custom requirements, supply availability and regulatory documentation.
